News
News from us and our partners
Tags
Topics
0 results
- News
Partnership with French cancer research network FFCD expands Bioptimus’s STELA programme
- News
Moon Surgical and Uncovr Announce First 20 Clinical Cases of Automated Operative Reporting on Maestro®
- News
Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database
- News
“Health is Wealth”: Why Europe must act now to strengthen its Life Sciences industry
- News
ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform
- News
TISSIUM secures €60 million to support commercial and clinical activities and platform expansion
- News
BrightHeart announces CE mark and European launch of its AI platform for prenatal ultrasound
- News
Latent Labs to launch Latent-Y Research Tier with a Live Event in London
- News
Mediar Therapeutics Announces First Cohorts Dosed in Phase 1 Clinical Trial of MTX-439 for Fibrosis Associated with Chronic Kidney Disease (CKD) and Additions to Clinical Advisory Board
- News
Micropep Files First Regulatory Submissions for Promisin™, a Novel Peptide Biofungicide with a New Mode of Action
- News
How a Sofinnova Partner's thesis became a $165M biotech
- News
Bionyra Pharma Launches with $165 million Oversubscribed Series A to Advance Clinical Stage Pipeline of Next Generation Biologics for Immune-Mediated Inflammatory Diseases
- News
deepc and University Hospital Basel Bring One of the World’s Most Widely Used Open-Source Medical AI Tools into Enterprise Healthcare Operations
- News
Sitryx Completes Enrollment in Phase 1b Trial of First-in-Class Oral PKM2 Modulator SYX-5219 in Atopic Dermatitis
- News
F2G and Shionogi Announce Positive Topline Results from Global Phase 3 OASIS Study Evaluating Oral Olorofim Versus AmBisome® Followed by Standard of Care in Patients with Invasive Aspergillosis